unlikely to be due to chance (p=0.011 by F test)."
Additionally, there is a sixth relevant meta-analysis(6) also published in The Lancet that supports positive results for homeopathy, but was not mentioned in Goldacre's commentary. The study authors concluded that "the results of our meta-analysis are not compatible with the hypothesis that the clinical effects of homeopathy are completely due to a placebo effect."
About Boiron: Boiron, world leader in homeopathy, is a $500 million
public company with 3,800 employees in more than 60 countries. It produces
more than 1,500 homeopathic medicines. For over 70 years, Boiron has been
committed to funding scientific research and educating the public and
healthcare professionals on homeopathic medicines. Boiron maintains the
highest manufacturing standards, complying with U.S. Food and Drug
Administration regulations, the Homeopathic Pharmacopoeia of the United
States and drug Good Manufacturing Practices.
1. Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homeopathy.
BMJ 1991; 302: 316-23.
2. Boissel JP, Cucherat M, Haugh M, Gauthier E. Critical literature review
on the effectiveness of homoeopathy: overview of data from homeopathic
medicine trials. Brussels, Belgium: Homoeopathic Medicine Research
Group. Report to the European Commission. 1996; 195-210.
3. Linde K, Melchart D. Randomized controlled trials of individualized
homeopathy: a state-of-the-art review. J Alter Complement Med 1998;
4. Cucherat M, Haugh MC, Gooch M, Boissel JP. Evidence of clinical
efficacy of homeopathy: a meta-analysis of clinical trials. Eur JClin
Pharmacol 2000; 56: 27-33.
5. Shang A, Huwiler-Muntener K, Nartey L, et al. Are the clinical effects
of homeopathy placebo effects? Comparative study of placebo-c
|SOURCE Boiron Laboratories|
Copyright©2007 PR Newswire.
All rights reserved